{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:48:11Z","timestamp":1792180091115,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jaci.2020.01.019","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T19:57:26Z","timestamp":1580155046000},"page":"752-756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Endotypes of chronic rhinosinusitis: Impact on management"],"prefix":"10.1016","volume":"145","author":[{"given":"Lars-Olaf","family":"Cardell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4r","family":"Stj\u00e4rne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Jonstam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Bachert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2020.01.019_bib1","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.jaci.2013.02.036","article-title":"Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology","volume":"131","author":"Akdis","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.019_bib2","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaci.2006.05.031","article-title":"Nasal interleukin-5 levels determine the response to anti-interleukin-5 treatment in nasal polyp patients","volume":"118","author":"Gevaert","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.019_bib3","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaci.2011.07.056","article-title":"Mepolizumab, a humanised anti-IL-5 monoclonal antibody, as treatment option for severe nasal polyposis","volume":"128","author":"Gevaert","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.019_bib4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2012.07.047","article-title":"Omalizumab is effective in allergic and non-allergic patients with nasal polyposis and co-morbid asthma","volume":"131","author":"Gevaert","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.019_bib5","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2016.05.041","article-title":"Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania","volume":"138","author":"Wang","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.019_bib6","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(08)61452-X","article-title":"Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease","volume":"372","author":"Anderson","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2020.01.019_bib7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jaip.2019.11.024","article-title":"Eosinophilic asthma","volume":"8","author":"Nelson","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.01.019_bib8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.rmed.2019.06.024","article-title":"Serum levels of IL-5, IL-6, IL-8, IL-13 and IL-17A in pre-defined groups of adult patients with moderate and severe bronchial asthma","volume":"154","author":"Dimitrova","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.jaci.2020.01.019_bib9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11882-019-0880-4","article-title":"Chronic rhinosinusitis with nasal polyps in older adults: clinical presentation, pathophysiology, and comorbidity","volume":"19","author":"Song","year":"2019","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2020.01.019_bib10","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","article-title":"Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers","volume":"137","author":"Tomassen","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.019_bib11","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1016\/j.jaip.2019.05.009","article-title":"Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis","volume":"7","author":"Stevens","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.01.019_bib12","doi-asserted-by":"crossref","first-page":"e97581","DOI":"10.1371\/journal.pone.0097581","article-title":"Mixed T helper cell signatures in chronic rhinosinusitis with and without polyps","volume":"9","author":"Derycke","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2020.01.019_bib13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.clim.2014.09.007","article-title":"Increased ILC2s in the eosinophilic nasal polyp endotype are associated with corticosteroid responsiveness","volume":"155","author":"Walford","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.019_bib14","article-title":"Innate lymphoid cells in the upper airways; importance of CD117 and IL-1RI expression","volume":"52","author":"Crombruggen","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2020.01.019_bib15","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jaci.2017.05.004","article-title":"The IL-33\/ST2 axis is crucial in type 2 airway responses induced by the S. aureus protease SplD","volume":"141","author":"Teufelberger","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.019_bib16","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1164\/rccm.201710-2112OC","article-title":"Staphylococcus aureus induces mucosal type 2 immune response via epithelial cell derived cytokines","volume":"198","author":"Lan","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.01.019_bib17","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.jaci.2017.01.019","article-title":"Extracellular eosinophilic traps in association with Staphylococcus aureus at the site of epithelial barrier defects in severe airway inflammation","volume":"139","author":"Gevaert","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.019_bib18","first-page":"364","article-title":"Protein crystallization promotes type 2 immunity and is reversible by antibody treatment","volume":"24","author":"Persson","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jaci.2020.01.019_bib19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jaci.2019.08.027","article-title":"Charcot-Leyden crystals promote neutrophilic inflammation in nasal polyposis","volume":"145","author":"Gevaert","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.019_bib20","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1111\/all.13919","article-title":"Subsetting reveals CD16highCD62Ldim neutrophils in chronic rhinosinusitis with nasal polyps","volume":"74","author":"Arebro","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.01.019_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/cea.13311","article-title":"Dividing neutrophils in subsets, reveals a significant role for activated neutrophils in the development of airway hyperreactivity","volume":"49","author":"Ekstedt","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2020.01.019_bib22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev-pathol-052016-100401","article-title":"Immunopathogenesis of chronic rhinosinusitis and nasal polyposis","volume":"12","author":"Schleimer","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jaci.2020.01.019_bib23","doi-asserted-by":"crossref","first-page":"e0136068","DOI":"10.1371\/journal.pone.0136068","article-title":"Association of mucosal organisms with patterns of inflammation in chronic rhinosinusitis","volume":"10","author":"Chalermwatanachai","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2020.01.019_bib24","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/lary.26391","article-title":"Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis","volume":"127","author":"DeConde","year":"2017","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2020.01.019_bib25","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/lary.27815","article-title":"Endoscopic sinus surgery for type-2 CRSwNP: an endotype-based retrospective study","volume":"129","author":"Alsharif","year":"2019","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2020.01.019_bib26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jama.2015.19330","article-title":"Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis. A\u00a0randomized clinical trial","volume":"315","author":"Bachert","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2020.01.019_bib27","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Dupilumab efficacy and safety in severe chronic rhinosinusitis with nasal polyps in the multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trials LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2020.01.019_bib28","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/all.13685","article-title":"Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis","volume":"74","author":"Jonstam","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.01.019_bib29","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01782-2017","article-title":"Care pathways for the selection of a biologic in severe asthma","volume":"50","author":"Bousquet","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2020.01.019_bib30","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jaci.2018.03.004","article-title":"Endotype-driven care pathways in patients with chronic rhinosinusitis","volume":"141","author":"Bachert","year":"2018","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920301081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920301081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:24:42Z","timestamp":1758792282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674920301081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0091674920301081"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2020.01.019","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endotypes of chronic rhinosinusitis: Impact on management","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2020.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}